MetaCap

Cytek Biosciences (CTKB) vs Standard BioTools (LAB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cytek Biosciences (CTKB) has outperformed Standard BioTools (LAB) over the past year, gaining 4.1% versus a loss of 54.3%. Over five years, CTKB leads with a -67.8% price change compared with -86.5% for LAB. Cytek Biosciences is the larger company by market cap ($800.4 million vs $249.1 million), about 3.2 times the size.

Cytek Biosciences converts more of its revenue into profit, with a net margin of -33.0% versus -87.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CTKB+4.08%LAB-54.28%
+26%-20%-65%
Nov 21, 20251 yearNov 20, 2026
CTKB-68.58%LAB-85.95%
+9%-42%-92%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CTKB versus LAB key metrics
MetricCTKBLAB
Share price$6.12$0.631
Market cap$800.40M$249.11M
1-day change-3.16%+2.82%
YTD return+21.19%-50.70%
1-year return+4.08%-54.28%
5-year return-67.82%-86.55%
Forward P/E87.43—
EPS (TTM)$-0.63$-0.09
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$201.49M$85.33M
Revenue growth (YoY)+0.52%-6.24%
Net income (latest FY)$-66.54M$-74.90M
Gross margin51.84%49.86%
Operating margin-20.04%-129.20%
Net margin-33.02%-87.77%
52-week high$6.39$1.72
52-week low$3.31$0.39
Distance from 52-week high-4.15%-63.31%
Analyst consensusbuynone
Avg. price target upside+6.21%+113.95%
Average volume1.31M1.16M
Shares outstanding130.78M394.79M
Employees703385
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Cytek Biosciences is about 3.2 times larger than Standard BioTools by market value ($800.40M vs $249.11M).
  • CTKB has outperformed LAB by 58.4 percentage points over the past year.
  • Cytek Biosciences is more profitable, keeping -33.0 cents of every revenue dollar as net income versus -87.8 cents for Standard BioTools.
  • Cytek Biosciences grew revenue faster in its latest fiscal year (+0.52% vs -6.24%).

About Cytek Biosciences

CTKB stock →

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems.

Industrials · Biotechnology: Laboratory Analytical Instruments · 703 employees

About Standard BioTools

LAB stock →

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments.

Industrials · Biotechnology: Laboratory Analytical Instruments · 385 employees

CTKB vs LAB FAQ

Which is bigger, Cytek Biosciences or Standard BioTools?

Cytek Biosciences (CTKB) is larger, with a market capitalization of $800.40M compared with $249.11M for Standard BioTools (LAB).

Which stock has performed better over the past year, CTKB or LAB?

CTKB returned +4.08% over the past 12 months, compared with -54.28% for LAB (price return, excluding dividends). Past performance does not predict future results.

Are Cytek Biosciences and Standard BioTools in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons